VEGFA and non-proliferative diabetic retinopathy: The antivascular endothelial growth factor (VEGF) therapy, panretinal photocoagulation, and vitrectomy could be adopted when severe nonproliferative diabetic retinopathy (NPDR), PDR, or clinically significant macular edema (CSME) occurs [4].